Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Ariel Nelson MD

Assistant Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology

Member of the Cancer Center

View Curriculum Vitae

Publications (33)

  • Homologous recombination repair (HRR) alterations may be passenger events in patients with advanced prostate cancer (PC) with high tumor mutational burden (hTMB) (Vineel Bhatlapenumarthi, Navonil De Sarkar, Anannya Patwari, Emmanuel S. Antonarakis, Ariel Ann Nelson, Deepak Kilari) J Clin Oncol J Clin Oncol 42, 2024 (suppl 4; abstr 206) 02/25/2024    
  • New phase 1 SURPASS trial cohort: Early-line ADP-A2M4CD8 T-cell receptor T-cell therapy plus pembrolizumab in urothelial carcinoma (David H Aggen, Alejandro Garcia, Jose M Saro Suarez, Amy Sauer, Sebastiano Cristiani, Francine Elizabeth Brophy, Sharon Streets, Elliot Norry, Ariel Ann Nelson, Deepak Kilari, Benjamin Garmezy, John A. Charlson, Jon Zugazagoitia, Emiliano Calvo, Irene Moreno, Victor Moreno, Christopher J. Hoimes, David S. Hong, Andres Cervantes) J Clin Oncol J Clin Oncol 42, 2024 (suppl 4; abstr TPS708) 02/25/2024    
  • Novel Targets in Development for Advanced Renal Cell Carcinoma (Bicky Thapa, Ariel Nelson & Deepak Kilari) Thapa, B., Nelson, A., Kilari, D. (2023). Novel Targets in Development for Advanced Renal Cell Carcinoma. In: McKay, R.R., Singer, E.A. (eds) Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma. Springer, Cham. https://doi.org/10.1007/978-3-031-40901-1_14 11/02/2023    
  • Novel targets in development for advanced renal cell carcinoma (Thapa B, Nelson A, Kilari D) Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma 1 November 2023:309-342 SCOPUS ID: 2-s2.0-85198394501 11/01/2023    
  • Outcomes of Antineoplastic Immunotherapy at a Large Healthcare Organization: Impact of Provider, Race and Socioeconomic Status. (Mirsky MM, Mitchell C, Hong A, Cao S, Fu P, Margevicius S, Wu S, Dowlati A, Nelson A, Selfridge JE, Ramaiya N, Hoimes C, Alahmadi A, Bruno DS) Cancer Manag Res 2023;15:913-927 PMID: 37674660 PMCID: PMC10478776 SCOPUS ID: 2-s2.0-85170261753 09/07/2023       4 Citations
  • Phase 2 study of batiraxcept (AVB-S6-500, an AXL inhibitor) as monotherapy, in combination with cabozantinib (cabo), and in combination with cabo and nivolumab (nivo) in patients with advanced clear cell renal cell carcinoma (ccRCC) (Katy Beckermann, Matthew T Campbell, Naomi B. Haas, Moshe Chaim Ornstein, Xin Gao, Shifeng S. Mao, Hans J. Hammers, Saby George, Ariel Ann Nelson, Theodore Stewart Gourdin, Holavanahalli Keshava-Prasad, Arif Hussain, Christopher J. Hoimes, Hongxia Yan, Vanessa Esquibel, Gail McIntyre, Robert B. Geller, Martin H Voss, Brian I. Rini, Neil J. Shah) J Clin Oncol J Clin Oncol 41, 2023 (suppl 16; abstr 4534) 07/01/2023    
  • Impact of pre-treatment hemoglobin (Hgb) on outcomes in metastatic castration resistant prostate cancer (mCRPC) with lutetium-177-PSMA-617 (Lu-177 (Ariel Ann Nelson, Kristin Riemersma, Kathryn A. Bylow, Michael Holt, Deepak Kilari) J Clin Oncol J Clin Oncol 41, 2023 (suppl 16; abstr e17065) 07/01/2023    
  • Disparities in medical oncology visit adherence among African American (AA) men with prostate cancer (pCa) (Ariel Ann Nelson, Christina Ladwig, Kristin Riemersma, Kathryn A. Bylow, Deepak Kilari) J Clin Oncol J Clin Oncol 41, 2023 (suppl 16; abstr e18671) 07/01/2023    
  • Phase 2 study of batiraxcept (AVB-S6-500, an AXL inhibitor) as monotherapy, in combination with cabozantinib (cabo), and in combination with cabo and nivolumab (nivo) in patients with advanced clear cell renal cell carcinoma (ccRCC). (Katy Beckermann, Matthew T Campbell, Naomi B. Haas, Moshe Chaim Ornstein, Xin Gao, Shifeng S. Mao, Hans J. Hammers, Saby George, Ariel Ann Nelson, Theodore Stewart Gourdin, Holavanahalli Keshava-Prasad, Arif Hussain, Christopher J. Hoimes, Hongxia Yan, Vanessa Esquibel, Gail McIntyre, Robert B. Geller, Martin H Voss, Brian I. Rini, Neil J. Shah) Journal of Clinical Oncology J Clin Oncol 41, 2023 (suppl 16; abstr 4534) 06/02/2023    
  • Impact of cytoreductive nephrectomy (CRN) on overall survival (OS) in metastatic non–clear cell renal cancer (nccRCC). (Ariel Ann Nelson, Aniko Szabo, Deepak Kilari) Journal of Clinical Oncology J Clin Oncol 41, 2023 (suppl 6; abstr 730) 06/02/2023    
  • Impact of pre-existing anemia and/or packed red blood cell transfusion prior to Radium-223 administration on oncologic outcomes. (Michael Pierro, Ariel Ann Nelson, John Xie, Albert Jang, Kathryn A. Bylow, Pedro C. Barata, Colleen Anne Lawton, Deepak Kilari) J Clin Oncol J Clin Oncol 41, 2023 (suppl 6; abstr 67) 03/16/2023    
  • Immunohistochemical (IHC) subtypes of metastatic bladder cancer (mBC) using GATA3 and CK5/6. (Ariel Ann Nelson, Mariel Molina Nunez, Kathryn A. Bylow, Aniko Szabo, Kenneth Iczkowski, Deepak Kilari) Journal of Clinical Oncology Journal of Clinical Oncology 41, no. 6_suppl (February 20, 2023) 557-557. 02/21/2023    
  • Outcomes of Antineoplastic Immunotherapy at a Large Healthcare Organization: Impact of Provider, Race and Socioeconomic Status (Mirsky MM, Mitchell C, Hong A, Cao S, Fu P, Margevicius S, Wu S, Dowlati A, Nelson A, Eva Selfridge J, Ramaiya N, Hoimes C, Alahmadi A, Bruno DS) Cancer Management and Research 2023;15:913-927 SCOPUS ID: 2-s2.0-85170261753 01/01/2023       4 Citations
  • Minding the Bathwater: Fertility and Reproductive Toxicity in the Age of Immuno-Oncology. (Kim AE, Nelson A, Stimpert K, Flyckt RL, Thirumavalavan N, Baker KC, Weinmann SC, Hoimes CJ) JCO Oncol Pract 2022 Dec;18(12):815-822 PMID: 36174117 PMCID: PMC10166412 SCOPUS ID: 2-s2.0-85144094142 09/30/2022       13 Citations
  • Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma. (Talukder R, Makrakis D, Lin GI, Diamantopoulos LN, Dawsey S, Gupta S, Carril-Ajuria L, Castellano D, de Kouchkovsky I, Jindal T, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Tripathi N, Agarwal N, Vather-Wu N, Zakharia Y, Morales-Barrera R, Devitt ME, Cortellini A, Fulgenzi CAM, Pinato DJ, Nelson A, Hoimes CJ, Gupta K, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Lu E, Kumar V, Lorenzo GD, Joshi M, Isaacsson-Velho P, Buznego LA, Duran I, Moses M, Barata P, Sonpavde G, Wright JL, Yu EY, Montgomery RB, Hsieh AC, Grivas P, Khaki AR) Clin Genitourin Cancer 2022 Dec;20(6):558-567 PMID: 36155169 PMCID: PMC10233855 SCOPUS ID: 2-s2.0-85138769237 09/27/2022       8 Citations
  • Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma. (Makrakis D, Talukder R, Lin GI, Diamantopoulos LN, Dawsey S, Gupta S, Carril-Ajuria L, Castellano D, de Kouchkovsky I, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Tripathi N, Agarwal N, Vather-Wu N, Zakharia Y, Morales-Barrera R, Devitt ME, Cortellini A, Fulgenzi CAM, Pinato DJ, Nelson A, Hoimes CJ, Gupta K, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Lu E, Kumar V, Lorenzo GD, Joshi M, Isaacsson-Velho P, Buznego LA, Duran I, Moses M, Jang A, Barata P, Sonpavde G, Yu EY, Montgomery RB, Grivas P, Khaki AR) Clin Genitourin Cancer 2022 Oct;20(5):e440-e452 PMID: 35778337 PMCID: PMC10257151 SCOPUS ID: 2-s2.0-85133310824 07/02/2022       14 Citations
  • Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin (Talukder R, Makrakis D, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Grant M, Lythgoe MP, Pinato DJ, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lorenzo GD, Joshi M, Velho PI, Buznego LA, Duran I, Moses M, Barata P, Sonpavde G, Yu EY, Wright JL, Grivas P, Khaki AR) Clinical Genitourinary Cancer April 2022;20(2):165-175 SCOPUS ID: 2-s2.0-85123348408 04/01/2022       5 Citations
  • Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin. (Talukder R, Makrakis D, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Grant M, Lythgoe MP, Pinato DJ, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lorenzo GD, Joshi M, Velho PI, Buznego LA, Duran I, Moses M, Barata P, Sonpavde G, Yu EY, Wright JL, Grivas P, Khaki AR) Clin Genitourin Cancer 2022 Apr;20(2):165-175 PMID: 35078711 PMCID: PMC8995351 SCOPUS ID: 2-s2.0-85123348408 01/27/2022       5 Citations
  • Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer. (Makrakis D, Talukder R, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Grant M, Lythgoe MP, Pinato DJ, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Di Lorenzo G, Joshi M, Isaacsson-Velho P, Buznego LA, Duran I, Moses M, Barata P, Sonpavde G, Yu EY, Wright JL, Grivas P, Khaki AR) BJU Int 2022 Nov;130(5):592-603 PMID: 34597472 PMCID: PMC10257152 SCOPUS ID: 2-s2.0-85117760063 10/02/2021       5 Citations
  • A Perspective on Withania somnifera Modulating Antitumor Immunity in Targeting Prostate Cancer. (Dubey S, Singh M, Nelson A, Karan D) J Immunol Res 2021;2021:9483433 PMID: 34485538 PMCID: PMC8413038 SCOPUS ID: 2-s2.0-85114595038 09/07/2021       10 Citations
  • Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes (Esagian SM, Khaki AR, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lythgoe MP, Pinato DJ, Murgic J, Fröbe A, Joshi M, Isaacsson Velho P, Hahn N, Alonso Buznego L, Duran I, Moses M, Barata P, Galsky MD, Sonpavde G, Yu EY, Msaouel P, Koshkin VS, Grivas P) BJU International August 2021;128(2):196-205 SCOPUS ID: 2-s2.0-85100561925 08/01/2021       24 Citations
  • Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial. (Hall WA, Bedi M, Kilari D, Bylow KA, Burfeind J, Johnstone C, Siker M, Currey A, See WA, Nelson A, Johnson S, Straza M, Lawton CAF) Pract Radiat Oncol 2021;11(6):527-533 PMID: 33848618 PMCID: PMC8638529 SCOPUS ID: 2-s2.0-85107984420 04/14/2021       4 Citations
  • Early Bone Metastases are Associated with Worse Outcomes in Metastatic Urothelial Carcinoma (Nelson, Ariel A.; Cronk, Robert J.; Lemke, Emily A.; Szabo, Aniko; Khaki, Ali R., Diamantopoulos, Leonidas N.; Grivas, Petros; Nezami, Behtash Ghazi; MacLennan, Gregory T.;Zhang, Tian; Hoimes, Christopher J.) Bladder Cancer 03/19/2021    
  • Early Bone Metastases are Associated with Worse Outcomes in Metastatic Urothelial Carcinoma. (Nelson AA, Cronk RJ, Lemke EA, Szabo A, Khaki AR, Diamantopoulos LN, Grivas P, Nezami BG, MacLennan GT, Zhang T, Hoimes CJ) Bladder Cancer 2021;7(1):33-42 PMID: 38993215 PMCID: PMC11181800 SCOPUS ID: 2-s2.0-85103035057 03/19/2021       6 Citations
  • Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes. (Esagian SM, Khaki AR, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lythgoe MP, Pinato DJ, Murgic J, Fröbe A, Joshi M, Isaacsson Velho P, Hahn N, Alonso Buznego L, Duran I, Moses M, Barata P, Galsky MD, Sonpavde G, Yu EY, Msaouel P, Koshkin VS, Grivas P) BJU Int 2021 Aug;128(2):196-205 PMID: 33556233 SCOPUS ID: 2-s2.0-85100561925 02/09/2021       24 Citations
  • Epidemiology and outcomes of primary pediatric lung malignancies: Updates from the SEER database. (Smith NJ, Mukherjee D, Wang Y, Brazauskas R, Nelson AA, Cortina CS) Am J Surg 2021 Oct;222(4):861-866 PMID: 33549297 PMCID: PMC8985451 SCOPUS ID: 2-s2.0-85100386252 02/08/2021       6 Citations
  • A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors. (Khaki AR, Li A, Diamantopoulos LN, Miller NJ, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Koshkin V, Park J, Alva A, Bilen MA, Stewart T, Santos V, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt M, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lythgoe MP, Pinato DJ, Murgic J, Fröbe A, Joshi M, Isaacsson Velho P, Hahn N, Alonso Buznego L, Duran I, Moses M, Barata P, Galsky MD, Sonpavde G, Yu EY, Shankaran V, Lyman GH, Grivas P) Eur Urol Oncol 2021 Jun;4(3):464-472 PMID: 33423945 PMCID: PMC8169524 SCOPUS ID: 2-s2.0-85107390322 01/12/2021       51 Citations
  • Early Bone Metastases are Associated with Worse Outcomes in Metastatic Urothelial Carcinoma (Nelson AA, Cronk RJ, Lemke EA, Szabo A, Khaki AR, Diamantopoulos LN, Grivas P, Nezami BG, MacLennan GT, Zhang T, Hoimes CJ) Bladder Cancer 2021;7(1):33-42 SCOPUS ID: 2-s2.0-85103035057 01/01/2021       6 Citations
  • Myocarditis associated with immune checkpoint inhibitor therapy: a case report of three patients. (Ansari-Gilani K, Tirumani SH, Smith DA, Nelson A, Alahmadi A, Hoimes CJ, Ramaiya NH) Emerg Radiol 2020 Aug;27(4):455-460 PMID: 32130542 SCOPUS ID: 2-s2.0-85080980782 03/05/2020       9 Citations
  • Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study. (Miller NJ, Khaki AR, Diamantopoulos LN, Bilen MA, Santos V, Agarwal N, Morales-Barrera R, Devitt M, Nelson A, Hoimes CJ, Shreck E, Assi H, Gartrell BA, Sankin A, Rodriguez-Vida A, Lythgoe M, Pinato DJ, Drakaki A, Joshi M, Isaacsson Velho P, Hahn N, Liu S, Alonso Buznego L, Duran I, Moses M, Jain J, Murgic J, Barata P, Tripathi A, Zakharia Y, Galsky MD, Sonpavde G, Yu EY, Lyman GH, Grivas P) J Urol 2020 Jul;204(1):63-70 PMID: 31971495 PMCID: PMC7289665 SCOPUS ID: 2-s2.0-85086346750 01/24/2020       42 Citations
  • Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors. (Khaki AR, Li A, Diamantopoulos LN, Bilen MA, Santos V, Esther J, Morales-Barrera R, Devitt M, Nelson A, Hoimes CJ, Shreck E, Assi H, Gartrell BA, Sankin A, Rodriguez-Vida A, Lythgoe M, Pinato DJ, Drakaki A, Joshi M, Isaacsson Velho P, Hahn N, Liu S, Alonso Buznego L, Duran I, Moses M, Jain J, Murgic J, Baratam P, Barata P, Tripathi A, Zakharia Y, Galsky MD, Sonpavde G, Yu EY, Shankaran V, Lyman GH, Grivas P) Cancer 2020 Mar 15;126(6):1208-1216 PMID: 31829450 PMCID: PMC7050422 SCOPUS ID: 2-s2.0-85076443880 12/13/2019       82 Citations
  • Autologous Hematopoietic Cell Transplantation in Patients With Multiple Myeloma: Effect of Age. (Dhakal B, Nelson A, Guru Murthy GS, Fraser R, Eastwood D, Hamadani M, Pasquini M, D'Souza A, Hari P) Clin Lymphoma Myeloma Leuk 2017 Mar;17(3):165-172 PMID: 28159578 SCOPUS ID: 2-s2.0-85011032026 02/06/2017       20 Citations
  • Presentation and management of post-allogeneic transplantation EBV-positive mucocutaneous ulcer. (Nelson AA, Harrington AM, Kroft S, Dahar MA, Hamadani M, Dhakal B) Bone Marrow Transplant 2016 Feb;51(2):300-2 PMID: 26457913 SCOPUS ID: 2-s2.0-84956921726 10/13/2015       32 Citations
    • Last update: 01/30/2025